Finally, a therapeutic angle for consideration may be inhibiting Cx26 in the context of metastatic disease, as Cx26 has been shown to enhance metastasis, likely by promoting lymphatic vessel invasion26,29. This evidence concerns the gene GJB2 and metastatic neoplasm.